PT1205190E - Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro - Google Patents

Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro

Info

Publication number
PT1205190E
PT1205190E PT00948291T PT00948291T PT1205190E PT 1205190 E PT1205190 E PT 1205190E PT 00948291 T PT00948291 T PT 00948291T PT 00948291 T PT00948291 T PT 00948291T PT 1205190 E PT1205190 E PT 1205190E
Authority
PT
Portugal
Prior art keywords
drug
oral use
present
iron oxides
medicinal compositions
Prior art date
Application number
PT00948291T
Other languages
English (en)
Inventor
Sako Kazuhiro
Sawada Toyohiro
Yoshihara Keiichi
Yoshioka Tatsunobu
Watanabe Shunsuke
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1205190(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PT1205190E publication Critical patent/PT1205190E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00948291T 1999-08-04 2000-08-01 Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro PT1205190E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04

Publications (1)

Publication Number Publication Date
PT1205190E true PT1205190E (pt) 2006-09-29

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00948291T PT1205190E (pt) 1999-08-04 2000-08-01 Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro

Country Status (17)

Country Link
EP (1) EP1205190B1 (pt)
JP (1) JP3462490B2 (pt)
KR (1) KR100507400B1 (pt)
CN (1) CN1193792C (pt)
AT (1) ATE324909T1 (pt)
AU (1) AU769807B2 (pt)
CA (1) CA2387705C (pt)
DE (1) DE60027728T2 (pt)
DK (1) DK1205190T3 (pt)
ES (1) ES2262528T3 (pt)
HU (1) HU229295B1 (pt)
MX (1) MXPA02001267A (pt)
NO (1) NO331834B1 (pt)
PL (1) PL200645B1 (pt)
PT (1) PT1205190E (pt)
RU (1) RU2220715C2 (pt)
WO (1) WO2001010466A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225206B2 (en) * 2002-04-24 2008-02-14 Forest Laboratories Holdings Limited Prevention and treatment of functional somatic disorders, including stress-related disorders
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010084397A2 (en) * 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
JP6630344B2 (ja) * 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
SI3360866T1 (sl) 2017-02-14 2019-04-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Mirabegronska predzdravila
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
DE69619979T2 (de) * 1995-04-14 2002-11-21 Pharma Pass Illkirch Graffenst Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
WO1999006045A1 (en) * 1997-08-01 1999-02-11 Elan Corporation, Plc Controlled release pharmaceutical compositions containing tiagabine
EP0901787B1 (en) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition

Also Published As

Publication number Publication date
AU769807B2 (en) 2004-02-05
RU2220715C2 (ru) 2004-01-10
DE60027728D1 (de) 2006-06-08
CN1373673A (zh) 2002-10-09
EP1205190B1 (en) 2006-05-03
CA2387705C (en) 2009-06-30
EP1205190A4 (en) 2004-01-21
AU6182100A (en) 2001-03-05
CA2387705A1 (en) 2001-02-15
HU229295B1 (en) 2013-10-28
HUP0202495A3 (en) 2004-05-28
MXPA02001267A (es) 2002-08-12
EP1205190A1 (en) 2002-05-15
DK1205190T3 (da) 2006-08-14
DE60027728T2 (de) 2007-04-26
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
NO20020516D0 (no) 2002-02-01
PL353154A1 (en) 2003-10-20
WO2001010466A1 (fr) 2001-02-15
KR20020046277A (ko) 2002-06-20
ATE324909T1 (de) 2006-06-15
CN1193792C (zh) 2005-03-23
KR100507400B1 (ko) 2005-08-10
JP3462490B2 (ja) 2003-11-05
PL200645B1 (pl) 2009-01-30
NO331834B1 (no) 2012-04-16
NO20020516L (no) 2002-02-01

Similar Documents

Publication Publication Date Title
PT1205190E (pt) Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
GEP20053474B (en) Glucocorticoid Receptor Modulators
BR0002880A (pt) Composição farmacêutica de liberação controlada termoformável sólida
DE60036807D1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
CA2143413A1 (en) Local Drug Delivery Film, for Periodontal Treatment
AP2003002763A0 (en) Controlled release formulations for oral administration
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
SE9401005L (sv) Farmaceutisk komposition med analgetisk aktivitet
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
SE9902935D0 (sv) Pharmaceutical compositions
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
ATE324103T1 (de) Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid
SE9902937D0 (sv) Pharmaceutical compositions
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
DE69501183T2 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
JPS5668619A (en) Nifedipine-containing solid composition
ATE7911T1 (de) Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE121297T1 (de) Neue polycarbophil enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung